Cargando…
Suppression of MD2 inhibits breast cancer in vitro and in vivo
PURPOSE: To explore the effects of the intervening measure targeting myeloid differentiation 2 (MD2) on breast cancer progression in vitro and in vivo. METHODS: The expression of MD2 in normal breast cells (Hs 578Bst) and three kinds of breast carcinoma cell lines (MCF-7, MDA-MB-231 s and 4T1) were...
Autores principales: | Zheng, S., Fu, W., Ma, R., Huang, Q., Gu, J., Zhou, J., Lu, K., Guo, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310507/ https://www.ncbi.nlm.nih.gov/pubmed/33733435 http://dx.doi.org/10.1007/s12094-021-02587-9 |
Ejemplares similares
-
Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo
por: Aziz, Moammir H., et al.
Publicado: (2015) -
Moscatilin Suppresses the Breast Cancer Both In Vitro and In Vivo by Inhibiting HDAC3
por: Su, Wenjie, et al.
Publicado: (2021) -
sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS
por: Zou, Yan, et al.
Publicado: (2016) -
miR-26b Mimic Inhibits Glioma Proliferation In Vitro and In Vivo Suppressing COX-2 Expression
por: Chen, Zheng-Gang, et al.
Publicado: (2019) -
Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo
por: Showalter, Loral, et al.
Publicado: (2020)